Nuclear receptors comprise a large family of ligand-sensitive transcription factors that regulate growth, development, metabolism, circadian rhythm and other physiological processes [1] [2] [3] . These receptors bind coactivator molecules in the presence of ligand and, to differing degrees, co-repressors in the absence of ligand, which facilitates local chromatin remodeling as well as target gene transcriptional activation or repression [4] [5] [6] [7] . Nuclear receptors contain two modules that contribute to their activation function: a ligand-insensitive activation domain known as activation function 1 (AF-1), located at the N terminus, and a ligand-dependent activation domain, known as AF-2, contained within the C-terminal ligand-binding domain (LBD) 8 .
a r t i c l e s
Nuclear receptors comprise a large family of ligand-sensitive transcription factors that regulate growth, development, metabolism, circadian rhythm and other physiological processes [1] [2] [3] . These receptors bind coactivator molecules in the presence of ligand and, to differing degrees, co-repressors in the absence of ligand, which facilitates local chromatin remodeling as well as target gene transcriptional activation or repression [4] [5] [6] [7] . Nuclear receptors contain two modules that contribute to their activation function: a ligand-insensitive activation domain known as activation function 1 (AF-1), located at the N terminus, and a ligand-dependent activation domain, known as AF-2, contained within the C-terminal ligand-binding domain (LBD) 8 .
In the absence of ligand, receptor LBDs differentially associate with the co-repressors N-CoR (nuclear co-repressor) and SMRT (silencing mediator of retinoid and thyroid receptors), which share significant amino acid sequence homology. Two regions within the aligned N-CoR and SMRT sequence bind to nuclear receptor LBDs [9] [10] [11] . The first region, called ID1 (refs. 9-11) , near N-CoR residues 2062-2084 and SMRT residues 2128-2150, contains the motif IxxI/VI. The second region, called ID2 (refs. 9-11) , near N-CoR 2270-2292 and SMRT 2235-2357, contains the motif LxxII. A third interaction domain has also been identified in N-CoR, although not in SMRT 12 .
In two of these studies, the motifs were combined into a single I/LxxI/VI motif 9, 10 , implying that the sequences should be aligned to preserve this motif (Fig. 1a) . Perissi et al. 11 used three-dimensional modeling to predict that the co-repressor α-helix should extend into volume normally occupied by the AF-2 α12 helix, and on the basis of co-repressor sequence alignments, they proposed an extended motif, LxxI/HIxxxI/L (Fig. 1b) . The subsequent crystal structure of a SMRT ID2 peptide bound to ligand-antagonized PPARα 13 confirmed the displacement of the AF-2 α12 helix, the extension of the co-repressor α-helix into volume normally occupied by α12 and the three-dimensional alignment of the ID2 LxxxIxxxL motif with the LxxLL coactivator motif. The latter was subsequently confirmed in other crystal structures of nuclear receptors bound to SMRT ID2 (refs. 14,15) . However, these data did not directly confirm the motif or alignment with respect to the ID1 sequences. Furthermore, there was evidence to suggest that the LxxxIxxxI/L motif might not apply to ID1 sequences 10, 16 . Thus, the motif and alignment necessary for ID1 binding was largely unclear.
Rev-erbα (encoded by NR1D1) is a heme receptor 17, 18 that represses the circadian clock transcription factor Bmal1, influencing the circadian period length and amplitude 19, 20 . In addition, Rev-erbα directly regulates a number of genes [21] [22] [23] [24] [25] [26] [27] [28] including the transcriptional coactivator PGC1α 29 , altering glucose, lipid and bile acid metabolism. Rev-erb lacks the AF-2 domain helix α12 (refs. 30, 31) and represses gene activity by associating with N-CoR 20, 32, 33 via selective binding to the ID1 CoRNR motif contained in N-CoR amino acids 2024-2065. The structure of the apo Rev-erbβ receptor 34 has been reported, as has that of the heme-bound Rev-erbβ receptor 35 , but the nature of corepressor association with the Rev-erb receptors is unclear. Binding of heme to the Rev-erbα is principally coordinated by a single histidine residue within α11 of the C terminus, resulting in marked restructuring of the receptor but providing little insight into the mode of N-CoR association. Thus, elucidating the molecular basis of Rev-erbα a r t i c l e s repression function is critical to further our understanding of nuclear hormone receptor-mediated repression as well as to provide insight into potential pharmacological manipulation of this receptor.
Here we present the 2.6 Å cocrystal structure of an N-CoR-derived ID1 CoRNR peptide bound to the human Rev-erbα LBD. The N-terminal N-CoR ID1 residues mediate a change in the receptor's C-terminal secondary structure and together form an unprecedented antiparallel β-sheet. Subsequently, N-CoR ID1 adopts a well-defined α-helical structure, with the CoRNR motif lying in the coactivator groove but not in register either with previously predicted co-repressor sequence alignments 11 or with the alignment based on the SMRT ID2 peptide ligand-antagonized PPARα crystal structure 13 . Structurebased sequence alignment corrects predicted alignments and suggests a new extended motif that better defines the binding requirements for ID1 and ID2 sequences and clarifies the differences among them. Contrasting the Rev-erbα LBD-N-CoR ID1 crystal structure and the heme-bound Rev-erbβ crystal structure reveals that N-CoR ID1 would potentially be displaced by significant steric hindrance between the β-sheet and the heme-dependent restructuring of the α-helix 3, receptor core residues and the porphyrin ring.
RESULTS

Rev-erba LBD-N-CoR ID1 cocrystal structure
Poor expression and solubility of full-length Rev-erbα LBD (281-614) necessitated the use of a soluble deletion mutant (281-614 Δ324-422) that lacks the proline-rich region between α1 and α3 containing the putative α2 and X-domain (406-418) 36 but that retains the C-terminal Y-domain (602-614). The mutated Rev-erbα was cocrystallized with an N-CoR (2045-2065) peptide, as indicated by thyroid receptor FRET (TR-FRET) data that confirmed preferential, high-affinity binding of ID1 CoRNR peptides by Rev-erbα (Supplementary Fig. 1 ). Despite the deleted region and the naturally absent AF-2 α12 helix, the global structure has ten α-helices and is mostly consistent with the canonical three-layer α-helical sandwich seen in many nuclear receptor LBD structures 37 (Fig. 1c,d) . The Rev-erbα α10 mediates dimer formation with α10 from a crystallographic symmetry-related monomer. Helix α1 is constructed of residues Pro284-Phe300, which are built into well-ordered electron density. However, subsequent residues Thr301-Pro323 and Tyr423-Thr431 are not defined by the data. Surface helix α3 is continuous and spans Val432-Leu457, followed by α3′ from Pro458-Ser464-with the Arg461 side chain hydrogenbonding to Gln465 and Gln468-and then by α4 from Gln465-Gly475. Thereafter, core α5 runs from Thr476-Phe484, where the backbone then meanders and disappears at residue Asp492. For residues 493-506, the anticipated canonical s1 and s2 β-strands could not be built into weak, disordered electron density. A remnant of α6 is defined by Glu507-Gly512 and is followed by a long stretch of welldefined helices that spans α7-α10 and continues into α11. Just after α10 Pro593, the C-terminal helix winds through His602 and is capped by Ser603. Subsequently, Lys605, whose side chain hydrogen-bonds to the Gly512 carboxyl, marks the transition into a new β-strand within the Y-domain, denoted sY, that runs from Leu607 before terminating at Val611 (Fig. 1c,d ). The exposed carboxyl of Leu606 and the amide of Ser608 hydrogen-bond to the α3 Trp436 and Ser440 side chains, further stabilizing this region. As an unprecedented nuclear receptor structural feature, the sY β-strand establishes a new molecular framework that enables Rev-erbα to form an antiparallel β-sheet with the N terminus of the N-CoR co-repressor peptide.
The N-CoR Thr2045 carboxyl hydrogen-bonds with the amide of Rev-erbα Val611 to initiate β-strand β1N, whose classic β-sheet hydrogen-bonding pattern terminates with the Ile2049 carboxyl and Leu607 amide (Fig. 1d) . Side chains from Phe609 and Leu607 provide hydrophobic packing on the top side of the β-sheet between Arg2047 and α3. Underpinning the receptor sY β-strand residues are a 2.7-Å hydrogen bond from the His2046 imidazole side chain to the Glu437 carboxylate and the Trp436 indole in α3 (Fig. 1d) . As sY Leu606 and Lys605 pass under N-CoR −5T2050, a change to the α-helix, termed α1N, is made at Leu2051, whose amide hydrogenbonds to the Lys605 carboxyl (2.7 Å) and whose side chain is directed toward the receptor core. Denoted as ID1 co-repressor motif residue −4, Leu2051 marks the first of a 15-residue amphipathic α-helix, where −4Leu2051, +1Ile2055, +4Ile2058, +5Ile2059 and +9Phe2063 travel up the entire co-regulator binding cleft with hydrophobic side chains pointing toward the mostly hydrophobic Rev-erbα binding surface ( Supplementary Fig. 2 ). Prior to +1Ile2055, the −2Asp2052 carboxylate hydrogen-bonds to the −5Thr2050 hydroxyl and the −1His2054 imidazole hydrogen-bonds to the conserved α3 Thr444 hydroxyl side chain (2.8 Å) (Fig. 2c,d ). Further stabilizing α1N on the C-terminal flank are water-mediated hydrogen bonds from the side chain of the highly conserved Lys455 to the +8Asp2062 backbone carboxyl (2.9 Å, 3.3 Å) and side chain (3.0 Å), a hydrogenbond from Lys473 to the +6Thr2060 side chain hydroxyl (3.0 Å), the terminal +11Arg2065 side chain to the +8Asp2062 side chain (3.0 Å) and the enclosure of the +9Phe2063 phenyl by Val451, Val469, Val472 and Arg461 and Gln465. The high degree of stability achieved by the bound N-CoR peptide is reflected by the fact that the entire 21-residue N-CoR peptide structure is well defined, owing to good-quality electron density, except for the +7Gln2061 side chain ( Table 1 and Supplementary Fig. 3 ).
Structural basis for co-repressor alignment revision
Both N-CoR ID1 bound to Rev-erbα and SMRT ID2 bound to ligand-antagonized PPARα adopt α-helical structures that bind coaxially in the space traditionally reserved for a coactivator and AF-2 α12 in activated nuclear receptors (Fig. 2a) . In marked contrast, the longer and better-defined N-CoR ID1 peptide extends more than one turn farther toward the bottom of the binding groove and terminates at −4Leu2051, whose side chain makes hydrophobic contacts with Phe443 and Phe477. The −4Leu2051 amide donates a hydrogen bond to the Lys605 carboxyl at the position where the antiparallel β-sheet is forged from the unwound α11 by analogy to apo Rev-erbβ. Notably, N-CoR −4Leu2051 occupies the same space as the GW6471 antagonist ethyl amide in the PPARα-SMRT ID2 structure ( Fig. 2a) and the conserved α12 tyrosine in activated PPAR structures 38 . Most notably, our structure reveals that −4Leu2051 is not the first residue in the three-turn LxxI/HIxxxL/I motif, as predicted from the PPARα-SMRT ID2 crystal structure 13 . We show in Figure 2b that the N-CoR ID1 ICQII CoRNR sequence actually aligns with the SMRT ID2 LEAII CoRNR, not the LADHI sequence as originally proposed 11, 13 . Therefore, this structure-based comparison requires a four-position N-terminal shift of the N-CoR ID1 and SMRT ID1 peptide sequences in order to correctly align the motif relative to the PPARα-SMRT ID2-GW6471 structure. Moreover, the realignment suggests a recognition and specificity role for the +9Phe2063 that aligns with tyrosine in SMRT ID1 and leucine in SMRT ID2 and N-CoR ID2.
Structure-guided analysis of repression by N-CoR ID1
We functionally challenged the unusual mode of CoRNR peptide interaction with N-CoR ID1 mutations that were tested for Rev-erbα LBD-binding affinity with an in vitro FRET assay ( Fig. 3a and Supplementary Table 1) . With the single solvent-exposed hydrogen bond between −9His2046 and Glu437 and the limited side chain contact between −7Leu2048 and Trp436, it may not be too surprising that alanine mutations cause minimal effects, as alanine sustains the β-sheet backbone interactions. However, it was rather unexpected that −4Leu2051A did not produce more of a loss, as the geometry and chemistry of the side chain appear well suited for the extremely hydrophobic environment provided by Phe443, Phe477, Leu607 and +1Ile2055. Evidently, the loss of three carbons makes little difference in this extremely hydrophobic region, nor does the loss of a hydrogen bond in the case of −1H2054A. By contrast, mutation of residues at the +1, +4 and +5 positions (Fig. 3a) , which comprise the core ICQII CoRNR motif, markedly reduced binding affinity for Rev-erbα LBD. Furthermore, a nearly nine-fold-reduced affinity for ID1 +9F2063A on Rev-erbα is in accord with the similarly weakened binding affinity for the L693A mutation at the equivalent position in the SMRT ID2 motif when assayed against PPARα and thyroid receptor β 38 . This and the structure-based alignment (Fig. 2b) lend credence to the idea that far-right flanking plays a greater role in mediating co-repressor binding and suggest that the core CoRNR motif could be extended to comprise I/LxxI/VIxxxF/Y/L.
The structural predictions were also tested in living cells using a mammalian two-hybrid assay. Co-transfection of the N-CoR CoRNR peptide fused to the DNA-binding domain (DBD) of the Gal4 transcription factor with Rev-erbα fused to the VP16 transcriptional activation domain led to the potent activation of a luciferase reporter (Fig. 3b) . Mutation in the CoRNR residues at the +1, +4 and +5 positions (Fig. 3b) abolished the interaction, whereas mutations in the extended N-terminal α-helix, residues −4 and −1, had little effect. Thus, the core ICQII motif was required for interaction with Rev-erbα, whereas the LADH extension was not.
To further explore the mode of core ICQII motif binding to Rev-erbα, and to determine whether this binding mode might occur with other nuclear receptors, we tested two chimeric CoRNR-derived peptide constructs for their ability to interact with thyroid receptor. Thyroid receptor preferentially binds N-CoR 39 where the ID1 and ID2 CoRNR sequences are ICQII and LEDII, respectively. Hu and Lazar 9 and Nagy et al. 10 originally aligned the ICQII with the LEDII (Fig. 1a) to derive the CoRNR motif I/LxxI/VI. This alignment suggests chimeric peptides such as ID1/2 (Fig. 3c) (Fig. 1b) . This alignment suggests that the ICQII sequence can be replaced with the IRKAL sequence, as in peptide ID1/2-RKAL (Fig. 3c) . Note that both peptides fit the original LxxxIxxxI/L N-terminally extended motif, but only the first peptide fits the I/LxxI/ VI CoRNR motif. In a mammalian two-hybrid assay testing the interaction of thyroid receptor and the described CoRNR peptides in cells, Gal-ID1/2 showed robust interaction whereas the alignment using the downstream RKAL sequence did not (Fig. 3d) . This result agrees with the structural work summarized in Figure 2 in supporting revision of the core CoRNR motif alignment.
N-CoR ID1 association may induce secondary structural change
The foremost structural difference between apo Rev-erbβ 34 and Rev-erbα LBD-N-CoR ID1 is the difference in secondary structure for equivalent Y-domain residues from α11 (β residues His568-Pro578) and the sY β-strand (α residues His602-Gln614) (Fig. 4a,b) . Rev-erbβ α11 residues Leu572, Leu573 and Phe575 (LLxF) ( Supplementary  Fig. 4 ) provide intramolecular hydrophobic packing with Leu482, Val413 and Trp402 (Fig. 4b,c) . The α3 break at Pro411 (ref. 34) (Fig. 4c) packs the Phe405 side chain deeper into the cognate ligand pocket, Trp402 fills space between α3 and α7, and the Glu403 side chain is directed to the solvent front. In contrast with the highly homologous Rev-erbα receptor bound to N-CoR ID1, the reconfigured Y-domain secondary structure creates an extended binding site that appears specific for ID1 CoRNR motifs. This places the αLeu606 below β1N, αLeu607 and αPhe609 (LLxF) on top of the sY β-strand that forms the antiparallel β-sheet with N-CoR (Fig. 4b,d) . Notably, this also positions the N-CoR −4Leu2051 directly where the equivalent α11 βLeu572 resided and assumed contact between −4Leu2051 and αLeu606, which may encourage the structural change and help to register the N-CoR peptide on the co-regulator groove ( Fig. 4b-d) . Furthermore, unlike α3 in apo Rev-erbβ, co-repressed Rev-erbα α3 is continuous, and the region from its N terminus to cells were co-transfected with Gal-DBD or Gal-N-CoR ID1 wild type or mutants, and either VP16 was fused to full-length Rev-erbα, as well as a 5xUAS luciferase reporter and β-galactosidase (to measure transfection efficiency). Relative interaction was determined as luciferase units normalized to β-galactosidase activity. All data is mean of three independent experiments ± s.e.m. (c) Nuclear hormone receptors use different modes of co-repressor binding. Gal ID1/2 construct is shown, which uses the two-turn 'CoRNR alignment'. Gal ID1/2-RKAL construct is shown, which uses the N-terminally extended α-helical motif sequence (Fig. 1b) . (d) Mammalian two-hybrid assay using indicated Gal-fusions co-transfected in 293T cells along with VP16-thyroid receptor (TR) and Gal-5xUAS-luciferase reporter. Following normalization to β-gal control, relative interaction is shown normalized to Gal-DBD.
a r t i c l e s αThr444 pivots toward sY, thus freeing αTrp436 to rotate under sY and αGlu473 to hydrogen-bond with N-CoR −9His2046. Assuming the described structural differences between the apo and ID1-bound states are shared by both the Rev-erbα and Rev-erbβ receptors, the N-CoR ID1-bound Rev-erbα structure reveals a potential molecular mechanism for a repression mode that occurs in the absence of heme. Also, despite the fact that the Rev-erbα α3 moved as much as 4.3 Å between α-carbons for αIle435/βIle401 and 2.7 Å for αPhe439/ βPhe405, the ligand-binding pocket remained occluded by many conserved hydrophobic side chains as previously described 34 . Therefore, to accommodate a ligand such as heme, a substantial change in tertiary structure and side chain orientation of the Y-domain histidine would have to occur 35 .
Comparison of CoRNR-and ligand-bound structures
Although heme binding stabilizes the interaction of full-length Rev-erbα with N-CoR, heme binding to the Rev-erbα LBD paradoxically destabilizes the interaction of Rev-erbα with the ID1 peptide 18 . This suggests that heme binding alters the conformation of Rev-erbα LBD in a manner that prevents interaction of the N-CoR-derived peptide in the absence of additional contacts with other regions of one or both proteins. Comparison of the apo Rev-erbα LBD-N-CoR ID1 and heme-bound Rev-erbβ 35 crystal structures shows that heme binding induces changes for α5 and 
conformed to α11 that is accompanied by a large-scale structural change in the bottom half of α3 (Fig. 5) . The conserved βTrp402 α-carbon located in α3 below βPro411 swings almost 8 Å left and away from the continuous α3 of the N-CoR structure and 10 Å from that in the apo Rev-erbβ structure and positions the α3 N terminus directly in the space occupied by the Rev-erbα LBD-N-CoR ID1 β-sheet (Fig. 5b) . The trajectory of the conserved tryptophan demonstrates the versatility of the receptor and how it adapts in response to different binding partners. Specifically, in apo Rev-erbβ, βTrp402 contributes hydrophobic packing at the base of the cognate ligand pocket, whereas in the heme-bound form, it contributes direct hydrophobic packing, along with βLeu572 and βPhe409. In apo Rev-erbα bound to N-CoR ID1, αTrp436 hydrogen-bonds αLeu606 and underpins sY. Heme binding also remodels core residues, such as βPhe409, that would produce steric clash with N-CoR −1His2054 (1.7 Å) and αPhe609 (2.8 Å), and potentially it would directly mediates contacts from the porphyrin ring to −4Ile2051 and αLeu607 (both <2.1 Å). Assuming heme-bound Rev-erbα would yield a similarly remodeled structure, these and other potential steric clashes are likely to interfere with ID1 binding. In all probability this explains why we have been unable to obtain crystals of the Rev-erbα LBD bound to N-CoR ID1 in the presence of heme (R.T.G., unpublished data).
DISCUSSION
We present the first crystal structure of an ID1 co-repressor peptide in complex with an apo nuclear receptor LBD. Bound to a deletion mutant of Rev-erbα LBD, the N-CoR ID1 peptide adopts an amphipathic α-helical structure that binds the co-regulator groove and overlaps the α-helix of ID2 CoRNR peptides bound to PPARα, ERRγ and PR. Consistent with earlier predictions 11 , the longer α1N extends farther into receptor volume normally occupied by the AF-2 helix of activated nuclear receptor structures. However, N-CoR Leu2051, originally predicted to be at the +1 position in the LxxxIxxxI/L motif, actually maps to the −4 position. Upon correction, the ID1 ICQII and the ID2 LEAII sequences are in register, consistent with the I/L xx I/V L motif for positions +1 through +5 (refs. 9,10) . Supporting this finding are cell-based and in vitro assays of N-CoR alanine mutants indicating that the +1Ile2055, +4Ile2058, +5Ile2059 have important roles in ID1 CoRNR binding. Also in agreement with the corrected alignment is that proper registry and presence of the CoRNR ID1 ICQII motif is required for binding to thyroid receptor. Furthermore, the corrected alignment suggests extending the motif to include the +9Phe2063 and equivalent SMRT tyrosine. The crystal structures also show that the N-CoR +9Phe2063 does superimpose reasonably well onto the +9 leucine in the ID2 co-repressor sequences and the final leucine of the LxxLL motif of coactivators. These observations and the nearly nine-fold reduction of binding for +9F2063A support extension of the corrected CoRNR motif to I/LxxI/VIxxxL/F/Y. Although there is some quantitative variation among the different peptides and receptors, the mutagenesis work presented here with ID1 peptides bound to Rev-erbα generally agrees with earlier mutagenesis work on ID2 peptides bound to PPARα and thyroid receptor 13, [40] [41] [42] showing that the +1, +4, +5 and +9 side chains tend to be the most important.
The formation of the antiparallel β-sheet between Rev-erbα and the N-CoR ID1 co-repressor peptide was unanticipated, especially considering that β-structure has never been observed for the corresponding residues in all other nuclear receptor structures. Nor did features in the Rev-erbβ structures or Rev-erbα sequences suggest that α11 could unwind to a β-strand. The presence of β-strand-enhancing residues before −4Leu2051 in ID1 strongly suggests that this elegant secondary structure switch is specifically tailored for the ID1 CoRNR motif. The remodeled Y-domain extends the ID1 binding surface by five residues, which in the case of apo and heme-bound Rev-erbβ have re-coiled to reform α11 and packed against the ligand-binding pocket. The insensitivity of −9His2046A or −7Leu2048A established that their side chain interactions contribute little to forming the β-sheet and indicate that insertion of β-strand-breaking residues from ID2 motifs or simultaneous deletion is probably required to dissect the key interactions. Thus our data and crystal structure help to better explain the molecular recognition and determinants for ID1 co-repressor binding to apo Rev-erbα LBD in vitro.
It is important to consider whether the intermolecular β-sheet could form in other nuclear receptor co-repressor complexes aside from the N-CoR ID1 sequence bound to Rev-erbα. In the region where N-CoR pairs with the sY β-strand, positions −9 through −5, and, in the extended part of the α-helix, positions −4 through −1, the N-CoR and SMRT ID1 sequences are similar to each other but quite different from the ID2 sequences. The ID1 sequences have amino acids that tend to promote α-helical and β-sheet structure, whereas the ID2 sequences tend to break these secondary structures. The N-CoR ID2 sequence has a proline that might interfere with the hydrogen bonding of the β-sheet (Supplementary Fig. 4b ). This suggests that ID2 CoRNR sequences probably would not induce the intermolecular β-sheet as presented here for N-CoR ID1 bound to Rev-erbα.
Rev-erbα has several structural features that probably contribute to β-sheet formation and ID1 selection. The Ser603 side chain helps cap α10 where it unwinds into the sY β-strand. An extensive hydrogen bond network involving the α3 W436 and S440 side chains effectively caps the edge of the sY β-strand, and the Trp436 indole also contributes to the lipophilic cluster below the sheet. The N-terminal α3 residues, Glu437 and Gln433, both hydrogen-bond to −9His2046. Farther along in α3, Thr444 hydrogen-bonds to −1His2054, and in α4, Lys473 hydrogen-bonds to +6Thr2060. Notably, −1His2054 and +6Thr2060 are both present in ID1 sequences but not in ID2. These receptor residues are all conserved in Rev-erbβ, except for Gln433, which is replaced by histidine. Trp436 is conserved in only RAR and ROR, out of all the nuclear receptors. Ser440 is conserved only in RAR, and a threonine is at this position in thyroid receptor, LXR, FXR and ER. Thr444 is conserved in thyroid receptor, RAR, ROR and others. The α3 Gln433 glutamine and Glu437 glutamate are probably less important, because their interactions are exposed to solvent, but they are conserved, respectively, in LXR and in RORγ, COUP and TLX (Supplementary Fig. 4) . Overall, the conservation of Trp436, Ser440 and Thr444 suggests that in addition to Rev-erbβ both RAR and ROR might bind ID1 co-repressor sequences via the β-sheet interaction seen here, provided any interference from the AF-2 α12 helix could be overcome in the case of RAR or ROR.
Comparison of the structure of Rev-erbα bound to the N-CoR ID1 with the heme-bound Rev-erbβ structure provides an explanation of the biochemical findings that heme titration displaces bound ID1 CoRNR peptide from the Rev-erbα LBD, as the intermolecular Rev-erbα β-sheet would be significantly disrupted by the bound heme and the remodeled Rev-erbα LBD. It also presents the possibility that a unique molecular mechanism is used by ID1 CoRNR to achieve repression in the absence of bound heme. Binding of N-CoR ID1 to Rev-erbα or β in this manner could represent a previously undescribed basal repression state, which might be further subject to alterations in repression function by association with heme or by other circadian and metabolic events. However, the structures do not provide insight into how heme recruits or stabilizes the interaction between full-length N-CoR and the Rev-erb proteins. Future studies
ONLINE METhODS
Crystallization and structure determination. Dilute solutions of purified human Rev-erbα (281-614Δ324-422) complexed with 2-3-fold molar excess of N-CoR CoRNR1 peptide ( 2045 NH 2 -THRLITLADHICQIITQDFAR-OH 2065 ) concentrated to 5-6 mg ml −1 were used to obtain diffraction-grade crystals. Vapor diffused hanging drops at 22 °C with a 1:1 (v/v) ratio of the Rev-erbα LBD-N-CoR ID1 complex and the precipitant solution produced 100-200 µM crystals within a few days. Precipitant solutions contained 6-9% (v/v) PEG 3350, 8% (v/v) glycerol, 200 mM proline and 80 mM HEPES at pH 7.5. Prior to flash freezing in liquid N 2 , the crystals were transiently mixed with a cryoprotectant solvent consisting of the precipitant solution amended with 20% (v/v) glycerol. X-ray diffraction data at 100 °K from a single crystal were collected at 1-Å wavelength using a MAR165 detector at the Industrial Macromolecular Crystallography Association-Collaborative Access Team, sector 17ID, at the Advanced Photon Source synchrotron. HKL2000 was used to index, integrate and scale the data 43 . The structure was solved using a proprietary liganded Rev-erbα LBD-N-CoR ID1 structure solved to 1.9 Å with heavy atom phases (unpublished data). A search model derived from hVDR (1db1) lacking helix 12 also yielded a valid solution by molecular replacement with AMORE or MOLREP [44] [45] [46] . The resulting structure contains one molecule in the asymmetric unit that forms a symmetric dimer along helix α10 with an adjacent molecule. The initial model was iteratively built with Quanta (Accelrys) and refined with CNX 47 , and the final structure was built with COOT 48 and refined with Refmac 45,46 using all hydrogens and maximum likelihood restraints. The crystallographic data and final refinement statistics are summarized in Table 1 . Reported interatomic distances are between heavy atoms unless specified and were measured with COOT or PyMol. The COOT SSM utility was used to superimpose previously published structures upon the Rev-erbα monomeric LBD. The deposited coordinates have a MolProbity 49 structure quality score of 1.89 (98%), and Ramachandran analysis within COOT indicated that 191 residues are in the preferred, 4 in the allowed and 2 in the outlier regions. Structure figures were generated with PyMol from Delano Scientific (http://www.pymol.org).
Time-resolved fluorescence energy transfer. From a collection of 70 different biotinylated coactivator or co-repressor peptides, N-CoR (2040-2065) and SMRT (2124-2149) with the CoRNR1 motif were identified to bind selectively to Reverbα. A volume of 12.5 µl at 20 nM of streptavidin-conjugated europium chelate in assay buffer (50 mM MOPS, 50 mM NaF, 0.05 mM CHAPS, 5 mM DTT) was added to 1 µl of each peptide at 500 µM concentration. After 1 h incubation, 12.5 µl of 20 nM recombinant Rev-erbα LBD labeled with 20 nM streptavidinconjugated allophycocyanin in assay buffer was added to the plate and allowed to equilibrate 2 h before reading on a Perkin Elmer ViewLux Microplate Imager. The data from four experiments were averaged and plotted against the peptide sequence. An increase in signal over background was considered as indicative of a potential interacting peptide with Rev-erbα.
For the alanine mutagenesis study, a 40 nM N-CoR peptide (2040-2065) labeled with 20 nM streptavidin-conjugated europium chelate was bound to 10 nM recombinant Rev-erbα LBD labeled with 10 nM streptavidin-conjugated allophycocyanin in the assay buffer. Volumes of 10 µl of the Rev-erbα LBD-N-CoR
